Log in to save to my catalogue

Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational...

Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4526215

Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study

About this item

Full title

Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study

Publisher

Cairo, Egypt: Hindawi Limiteds

Journal title

Multiple Sclerosis International, 2015-01, Vol.2015 (2015), p.130-136

Language

English

Formats

Publication information

Publisher

Cairo, Egypt: Hindawi Limiteds

More information

Scope and Contents

Contents

Objective. The aim of this prospective observational multicenter postmarketing study was to evaluate fingolimod efficacy in a real world clinical setting. Methods. One hundred forty-two subjects with relapsing-remitting multiple sclerosis (RRMS) were enrolled in three multiple sclerosis centers throughout Central and Southern Italy between January...

Alternative Titles

Full title

Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4526215

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4526215

Other Identifiers

ISSN

2090-2654

E-ISSN

2090-2662

DOI

10.1155/2015/763418

How to access this item